Join to View Full Profile
1611 NW 12th Ave# M851Miami, FL 33136
Phone+1 305-243-4664
Fax+1 305-243-8470
Dr. Preston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Miami/Jackson Health SystemFellowship, Nephrology, 1986 - 1988- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1979 - 1982
University of California San Diego School of MedicineClass of 1979
Certifications & Licensure
FL State Medical License 1981 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Clinical Trials
- Nebivolol Versus Metoprolol: Sodium Sensitivity Start of enrollment: 2010 Dec 01
- Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment Start of enrollment: 2014 Sep 01
- A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment Start of enrollment: 2020 Jul 09
- Join now to see all
Publications & Presentations
PubMed
- Effect of Hepatic Impairment on Trilaciclib Pharmacokinetics.Chao Li, Richard A Preston, Emily Dumas, Andrew Beelen, Thomas C Marbury
Journal of Clinical Pharmacology. 2024-08-01 - 1 citationsPharmacokinetics and Safety of Multiple-Dose Alpelisib in Participants with Moderate or Severe Hepatic Impairment: A Phase 1, Open-Label, Parallel Group Study.Thomas Marbury, Mona El-Hashimy, Lars Blumenstein, Franck Letellier, Tirtha Sengupta
Journal of Cancer. 2023-01-01 - 45 citationsPharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment.Sima S Toussi, Joel Michael Neutel, Jesus Navarro, Richard Alfred Preston, Haihong Shi
Clinical Pharmacology and Therapeutics. 2022-10-01
Press Mentions
COVID Lockdowns Were a Giant Experiment. It Was a FailureNovember 1st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
